The Japanese guideline for cervical cancer screening

Chisato Hamashima, Daisuke Aoki, Etsuko Miyagi, Eiko Saito, Tomio Nakayama, Motoyasu Sagawa, Hiroshi Saito, Tomotaka Sobue

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Cervical cancer is the 11th leading cause of death from cancer for females in Japan. In 2005, there were 2486 deaths from cervical cancer, accounting for 1.8% of the total number of cancer deaths in Japan. Cervical cancer screening using conventional cytology has been conducted worldwide. The guideline for cervical cancer screening was developed based on the established method. The efficacies of conventional and liquid-based cytology, human papillomavirus testing alone and two combination methods were evaluated. On the basis of the balance of the benefits and harms, recommendations for population-based and opportunistic screening were formulated. Five methods of cervical cancer screening were evaluated. On the basis of the analytic framework involving key questions, 3450 articles published from January 1985 to October 2007 were selected using MEDLINE and other methods. After the systematic literature review, 66 articles were confirmed. The results of 33 studies were consistent, and the evidence was sufficient to evaluate the effect of conventional cytology screening. The accuracy of liquid-based cytology was almost equal to that of conventional cytology. Although human papillomavirus testing and combination methods showed high sensitivity, no study has evaluated the reduction in mortality from cervical cancer. Except for the possibility of overdiagnosis, no serious adverse effects of cervical cancer screening were found. Cervical cancer screening using conventional and liquid-based cytology is recommended for population-based and opportunistic screening due to sufficient evidence. Cervical cancer screening using either human papillomavirus testing alone or two combination methods is not recommended for population-based screening due to insufficient evidence.

Original languageEnglish
Article numberhyq036
Pages (from-to)485-502
Number of pages18
JournalJapanese Journal of Clinical Oncology
Volume40
Issue number6
DOIs
Publication statusPublished - 2010 Apr 30

Fingerprint

Early Detection of Cancer
Uterine Cervical Neoplasms
Guidelines
Cell Biology
Japan
Population
MEDLINE
Cause of Death
Neoplasms
Mortality

Keywords

  • Cancer screening
  • Cervical cancer
  • Conventional cytology
  • Guideline
  • HPV testing
  • Liquid-based cytology
  • Recommendation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Hamashima, C., Aoki, D., Miyagi, E., Saito, E., Nakayama, T., Sagawa, M., ... Sobue, T. (2010). The Japanese guideline for cervical cancer screening. Japanese Journal of Clinical Oncology, 40(6), 485-502. [hyq036]. https://doi.org/10.1093/jjco/hyq036

The Japanese guideline for cervical cancer screening. / Hamashima, Chisato; Aoki, Daisuke; Miyagi, Etsuko; Saito, Eiko; Nakayama, Tomio; Sagawa, Motoyasu; Saito, Hiroshi; Sobue, Tomotaka.

In: Japanese Journal of Clinical Oncology, Vol. 40, No. 6, hyq036, 30.04.2010, p. 485-502.

Research output: Contribution to journalArticle

Hamashima, C, Aoki, D, Miyagi, E, Saito, E, Nakayama, T, Sagawa, M, Saito, H & Sobue, T 2010, 'The Japanese guideline for cervical cancer screening', Japanese Journal of Clinical Oncology, vol. 40, no. 6, hyq036, pp. 485-502. https://doi.org/10.1093/jjco/hyq036
Hamashima C, Aoki D, Miyagi E, Saito E, Nakayama T, Sagawa M et al. The Japanese guideline for cervical cancer screening. Japanese Journal of Clinical Oncology. 2010 Apr 30;40(6):485-502. hyq036. https://doi.org/10.1093/jjco/hyq036
Hamashima, Chisato ; Aoki, Daisuke ; Miyagi, Etsuko ; Saito, Eiko ; Nakayama, Tomio ; Sagawa, Motoyasu ; Saito, Hiroshi ; Sobue, Tomotaka. / The Japanese guideline for cervical cancer screening. In: Japanese Journal of Clinical Oncology. 2010 ; Vol. 40, No. 6. pp. 485-502.
@article{08d2cb995a19497ca3b4c8d837c34a18,
title = "The Japanese guideline for cervical cancer screening",
abstract = "Cervical cancer is the 11th leading cause of death from cancer for females in Japan. In 2005, there were 2486 deaths from cervical cancer, accounting for 1.8{\%} of the total number of cancer deaths in Japan. Cervical cancer screening using conventional cytology has been conducted worldwide. The guideline for cervical cancer screening was developed based on the established method. The efficacies of conventional and liquid-based cytology, human papillomavirus testing alone and two combination methods were evaluated. On the basis of the balance of the benefits and harms, recommendations for population-based and opportunistic screening were formulated. Five methods of cervical cancer screening were evaluated. On the basis of the analytic framework involving key questions, 3450 articles published from January 1985 to October 2007 were selected using MEDLINE and other methods. After the systematic literature review, 66 articles were confirmed. The results of 33 studies were consistent, and the evidence was sufficient to evaluate the effect of conventional cytology screening. The accuracy of liquid-based cytology was almost equal to that of conventional cytology. Although human papillomavirus testing and combination methods showed high sensitivity, no study has evaluated the reduction in mortality from cervical cancer. Except for the possibility of overdiagnosis, no serious adverse effects of cervical cancer screening were found. Cervical cancer screening using conventional and liquid-based cytology is recommended for population-based and opportunistic screening due to sufficient evidence. Cervical cancer screening using either human papillomavirus testing alone or two combination methods is not recommended for population-based screening due to insufficient evidence.",
keywords = "Cancer screening, Cervical cancer, Conventional cytology, Guideline, HPV testing, Liquid-based cytology, Recommendation",
author = "Chisato Hamashima and Daisuke Aoki and Etsuko Miyagi and Eiko Saito and Tomio Nakayama and Motoyasu Sagawa and Hiroshi Saito and Tomotaka Sobue",
year = "2010",
month = "4",
day = "30",
doi = "10.1093/jjco/hyq036",
language = "English",
volume = "40",
pages = "485--502",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - The Japanese guideline for cervical cancer screening

AU - Hamashima, Chisato

AU - Aoki, Daisuke

AU - Miyagi, Etsuko

AU - Saito, Eiko

AU - Nakayama, Tomio

AU - Sagawa, Motoyasu

AU - Saito, Hiroshi

AU - Sobue, Tomotaka

PY - 2010/4/30

Y1 - 2010/4/30

N2 - Cervical cancer is the 11th leading cause of death from cancer for females in Japan. In 2005, there were 2486 deaths from cervical cancer, accounting for 1.8% of the total number of cancer deaths in Japan. Cervical cancer screening using conventional cytology has been conducted worldwide. The guideline for cervical cancer screening was developed based on the established method. The efficacies of conventional and liquid-based cytology, human papillomavirus testing alone and two combination methods were evaluated. On the basis of the balance of the benefits and harms, recommendations for population-based and opportunistic screening were formulated. Five methods of cervical cancer screening were evaluated. On the basis of the analytic framework involving key questions, 3450 articles published from January 1985 to October 2007 were selected using MEDLINE and other methods. After the systematic literature review, 66 articles were confirmed. The results of 33 studies were consistent, and the evidence was sufficient to evaluate the effect of conventional cytology screening. The accuracy of liquid-based cytology was almost equal to that of conventional cytology. Although human papillomavirus testing and combination methods showed high sensitivity, no study has evaluated the reduction in mortality from cervical cancer. Except for the possibility of overdiagnosis, no serious adverse effects of cervical cancer screening were found. Cervical cancer screening using conventional and liquid-based cytology is recommended for population-based and opportunistic screening due to sufficient evidence. Cervical cancer screening using either human papillomavirus testing alone or two combination methods is not recommended for population-based screening due to insufficient evidence.

AB - Cervical cancer is the 11th leading cause of death from cancer for females in Japan. In 2005, there were 2486 deaths from cervical cancer, accounting for 1.8% of the total number of cancer deaths in Japan. Cervical cancer screening using conventional cytology has been conducted worldwide. The guideline for cervical cancer screening was developed based on the established method. The efficacies of conventional and liquid-based cytology, human papillomavirus testing alone and two combination methods were evaluated. On the basis of the balance of the benefits and harms, recommendations for population-based and opportunistic screening were formulated. Five methods of cervical cancer screening were evaluated. On the basis of the analytic framework involving key questions, 3450 articles published from January 1985 to October 2007 were selected using MEDLINE and other methods. After the systematic literature review, 66 articles were confirmed. The results of 33 studies were consistent, and the evidence was sufficient to evaluate the effect of conventional cytology screening. The accuracy of liquid-based cytology was almost equal to that of conventional cytology. Although human papillomavirus testing and combination methods showed high sensitivity, no study has evaluated the reduction in mortality from cervical cancer. Except for the possibility of overdiagnosis, no serious adverse effects of cervical cancer screening were found. Cervical cancer screening using conventional and liquid-based cytology is recommended for population-based and opportunistic screening due to sufficient evidence. Cervical cancer screening using either human papillomavirus testing alone or two combination methods is not recommended for population-based screening due to insufficient evidence.

KW - Cancer screening

KW - Cervical cancer

KW - Conventional cytology

KW - Guideline

KW - HPV testing

KW - Liquid-based cytology

KW - Recommendation

UR - http://www.scopus.com/inward/record.url?scp=77953425536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953425536&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyq036

DO - 10.1093/jjco/hyq036

M3 - Article

C2 - 20436034

AN - SCOPUS:77953425536

VL - 40

SP - 485

EP - 502

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 6

M1 - hyq036

ER -